Fundz

KGK Science Secures Growth Investment Led by Maxim Partners to Expand Capabilities. Financial terms were not disclosed.

PRIVATEJul 27, 2026

Round Type

Venture

LondonBiotechnologyHealth CareDietary Supplements

Investors

Maxim Partners

Description

KGK Science has received a growth investment led by Maxim Partners. This investment will support the expansion of clinical trial capacity and enhance regulatory services. The existing management team will continue leading the business. This marks an important step forward for KGK as it seeks to better serve its clients globally.

Quick answer

KGK Science raised an undisclosed amount in a funding round, dated July 27, 2026. Investors: Maxim Partners. KGK Science is based in London, Ontario, Canada.

How much did KGK Science raise?
KGK Science raised an undisclosed amount in a funding round on July 27, 2026.
Who invested in KGK Science?
Maxim Partners is named as investors in this round.
What does KGK Science do?
KGK Science Inc. is a leading North American contract research organization specializing in clinical trials and regulatory services for the dietary supplement, nutraceutical, and consumer health industries.
Where is KGK Science based and how big is it?
KGK Science is based in London, Ontario, Canada. Fundz records about 68 employees.
Who are the decision-makers at KGK Science?
Fundz holds 3 contacts at KGK Science, including the Director of Sales and Client Services. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Dietary Supplements and Biotechnology around the same time

Companies in the same sectors as KGK Science that raised within 45 days of this round, from Fundz verified event records.

  • The Func. Lab raised $1.5M (Seed) on June 29, 2026.
  • Epsilon Health raised $28M on September 10, 2026.
  • AQ BioTech raised $2.9M (Seed) on September 10, 2026.
  • CONNECTA Therapeutics raised $3.6M (Seed) on September 10, 2026.
  • Cerenome, Inc. raised $20M (Debt Financing) on September 10, 2026.
  • Positron raised $875M (Series C) on September 10, 2026.

Who to call at KGK Science, and when

A new round usually means KGK Science is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day KGK Science raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at KGK Science, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at KGK Science. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

KGK Science

Location

London, Ontario, Canada

About

KGK Science Inc. is a leading North American contract research organization specializing in clinical trials and regulatory services for the dietary supplement, nutraceutical, and consumer health industries. Founded in 1997, KGK has completed more than 400 clinical trials and published over 150 peer-reviewed scientific publications. The company helps consumer health brands develop scientifically validated products through its clinical research and regulatory consulting services. KGK is headquartered in London, Ontario.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment KGK Science raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsBibiane, Director of Sales and Client Services hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for KGK Science's next move

See what Strategic adds

KGK Science raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.